Showing 34,869 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

People & personal stories

Gregg Gonsalves Blends Activism and Science

Editor's pick
The New York Times
9 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
PrEP programmes & uptake

Racism, marginalisation and PrEP stereotypes affect PrEP uptake for black MSM in London

News
9 April 2019
Employment

Employers’ unlawful vetting of job applicant health conditions and disabilities persists, says NAT

Editor's pick
National AIDS Trust
8 April 2019
Opportunistic infections

A Mysterious Infection, Spanning the Globe in a Climate of Secrecy

Editor's pick
New York Times
8 April 2019
TB diagnosis

Xpert testing to find TB in people with advanced HIV at diagnosis saves lives, study finds

Editor's pick
Science Speaks
8 April 2019
PrEP science

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

Editor's pick
Gilead press release
8 April 2019
Hepatitis C transmission & prevention

English clinic survey finds that 40% of gay men with new hepatitis C infections are HIV negative

News
7 April 2019
Government, leadership & policy

The World’s Largest HIV Epidemic in Crisis: HIV in South Africa

Editor's pick
Center for Strategic and International Studies
5 April 2019
Migrants, refugees & displaced people

UK: Ministers accused of cover-up over migrant health reports

Editor's pick
The Guardian
5 April 2019
PrEP policies & guidelines

The CDC Director got shouted down by angry AIDS activists during a completely tone deaf speech

Editor's pick
LGBTQ Nation
5 April 2019
Treatment guidelines

Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Editor's pick
MedPage Today
5 April 2019
Activism & civil society

8 Advocates Share Their Top HIV Policy Issues at AIDSWatch 2019

Editor's pick
The Body
5 April 2019
Men who have sex with men (MSM)

The Unfinished Business of HIV: 2018 Annual Report

Editor's pick
MPact Global Action for Gay Men’s Health and Rights
5 April 2019
The biology of HIV transmission

Your sexual partners can change your microbiome, finds a study in mice

Editor's pick
STAT
5 April 2019
Transgender people

Providing care for trans women with HIV/AIDS in Peru

Editor's pick
The Lancet (free registration required)
5 April 2019
Confidentiality, consent & medical ethics

Inside Grindr, fears that China wanted to access user data via HIV research

Editor's pick
NBC News
5 April 2019
Treatment simplification strategies

ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks

Editor's pick
ViiV press release
5 April 2019
PrEP science

Raltegravir plus lamivudine is likely to work as PrEP

News
5 April 2019
Ageing & HIV

Clusters of co-morbidities in people living with HIV show major non-HIV medical needs

News
5 April 2019
Behaviour change interventions

Meet Marlo: the go-to source of information about HIV

Editor's pick
UNAIDS
4 April 2019
PrEP policies & guidelines

PrEP Impact Trial Update – April 2019

Editor's pick
NHS England
4 April 2019
Self-testing & home testing

Australia's first HIV self-testing device goes on sale today

Editor's pick
QNews
4 April 2019
Circumcision

Systematic analysis suggests that circumcision helps protect MSM from infection with HIV

News
4 April 2019